CD19 CAR T cells for adults with relapsed or refractory acute lymphoblastic leukaemia

被引：10
|
作者：
Maus, Marcela V. [1 ]
机构：
[1] Massachusetts Gen Hosp, Cellular Immunotherapy Program, Ctr Canc, Charlestown, MA 02129 USA
来源：
LANCET | 2021年 / 398卷 / 10299期
关键词：
B-CELL;
D O I：
10.1016/S0140-6736(21)01289-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：466 / 467
页数：2
相关论文
共 50 条
  • [1] Sequential CD19 and CD22 CAR-T Therapy in Relapsed/Refractory Acute Lymphoblastic Leukemia
    Yang, Tingting
    Dong, Yetian
    Zhang, Mingming
    Feng, Jingjing
    Fu, Shan
    Xiao, Pingnan
    Hong, Ruimin
    Xu, Huijun
    Cui, Jiazhen
    Huang, Simao
    Wei, Guoqing
    Chang, Alex H.
    Huang, He
    Hu, Yongxian
    BLOOD, 2024, 144 : 2819 - 2819
  • [2] Correction to: Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia
    Hanren Dai
    Zhiqiang Wu
    Hejin Jia
    Chuan Tong
    Yelei Guo
    Dongdong Ti
    Xiao Han
    Yang Liu
    Wenying Zhang
    Chunmeng Wang
    Yajing Zhang
    Meixia Chen
    Qingming Yang
    Yao Wang
    Weidong Han
    Journal of Hematology & Oncology, 13
  • [3] Safety and efficacy of CD19/CD22 CAR T cells in children and young adults with relapsed/refractory ALL
    Shalabi, Haneen
    Yates, Bonnie
    Shahani, Shilpa
    Qin, Haiying
    HIghfill, Steven L.
    Panch, Sandhya
    Tran, Minh
    Stroncek, David
    Hoffman, Leah
    Little, Lauren
    Graap, Katherine
    Stetler-Stevenson, Maryalice
    Yuan, Constance
    Wang, Hao-Wei
    Fry, Terry J.
    Shah, Nirali N.
    CANCER RESEARCH, 2020, 80 (16)
  • [4] Disease Burden and Transplant on Long-Term Survival After CD19 CAR T Cells in Adults with Relapsed Acute Lymphoblastic Leukemia
    Park, Jae
    Rivere, Isabelle
    Wang, Xiuyan
    Senechal, Brigitte
    Curran, Kevin
    Sauter, Craig
    Wang, Yongzeng
    Li, Daniel
    Brentjens, Renier
    Sadelain, Michel
    MOLECULAR THERAPY, 2017, 25 (05) : 26 - 26
  • [5] Safety and efficacy of a humanized CD19 chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic leukemia
    Shi, Ming
    Li, Li
    Wang, Shiyuan
    Cheng, Hai
    Chen, Wei
    Sang, Wei
    Qi, Kunming
    Li, Zhenyu
    Wang, Gang
    Li, Huizhong
    Lan, Jianping
    Huang, Jinqi
    Fei, Xiaoming
    Yu, Min
    Li, Fei
    Qiao, Jianlin
    Wu, Qingyun
    Zeng, Lingyu
    Jing, Guangjun
    Zheng, Junnian
    Gale, Robert Peter
    Xu, Kailin
    Cao, Jiang
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (06) : 711 - 718
  • [6] Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia
    Gu, Runxia
    Liu, Fang
    Zou, Dehui
    Xu, Yingxi
    Lu, Yang
    Liu, Bingcheng
    Liu, Wei
    Chen, Xiaojuan
    Liu, Kaiqi
    Guo, Ye
    Gong, Xiaoyuan
    Lv, Rui
    Chen, Xia
    Zhou, Chunlin
    Zhong, Mengjun
    Wang, Huijun
    Wei, Hui
    Mi, Yingchang
    Qiu, Lugui
    Lv, Lulu
    Wang, Min
    Wang, Ying
    Zhu, Xiaofan
    Wang, Jianxiang
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [7] Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy
    Lihong An
    Yuehui Lin
    Biping Deng
    Zhichao Yin
    Defeng Zhao
    Zhuojun Ling
    Tong Wu
    Yongqiang Zhao
    Alex H. Chang
    Chunrong Tong
    Shuangyou Liu
    BMC Cancer, 22
  • [8] Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia
    Runxia Gu
    Fang Liu
    Dehui Zou
    Yingxi Xu
    Yang Lu
    Bingcheng Liu
    Wei Liu
    Xiaojuan Chen
    Kaiqi Liu
    Ye Guo
    Xiaoyuan Gong
    Rui Lv
    Xia Chen
    Chunlin Zhou
    Mengjun Zhong
    Huijun Wang
    Hui Wei
    Yingchang Mi
    Lugui Qiu
    Lulu Lv
    Min Wang
    Ying Wang
    Xiaofan Zhu
    Jianxiang Wang
    Journal of Hematology & Oncology, 13
  • [9] Two Ways of Targeting a CD19 Positive Relapse of Acute Lymphoblastic Leukaemia after Anti-CD19 CAR-T Cells
    Grain, Audrey
    Ollier, Jocelyn
    Guillaume, Thierry
    Chevallier, Patrice
    Le Calvez, Baptiste
    Eveillard, Marion
    Clemenceau, Beatrice
    BIOMEDICINES, 2023, 11 (02)
  • [10] Locally produced CD19 CAR T cells leading to clinical remissions in medullary and extramedullary relapsed acute lymphoblastic leukemia
    Jacoby, Elad
    Bielorai, Bella
    Avigdor, Abraham
    Itzhaki, Orit
    Hutt, Daphna
    Nussboim, Vered
    Meir, Amilia
    Kubi, Adva
    Levy, Michal
    Zikich, Dragoslav
    Zeltzer, Li-at
    Brezinger, Karin
    Schachter, Jacob
    Nagler, Arnon
    Besser, Michal J.
    Toren, Amos
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (12) : 1485 - 1492
12345